HOME | SITEMAP

  • CORPORATE
  • PRODUCTS
  • INVESTORS
  • NEWS
  • CONTACT
  • About Kane
  • Corporate Strategy
  • Management Team
  • Board of Directors
  • Scientific Advisory Council
  • Careers
  • Product Pipeline
  • DispersinB®
  • Aledex®
  • CSP
  • KBI Antibacterial Disinfectant
  • What is Biofilm?
  • Stock Quote
  • Events & Presentations
  • Financial Reports
  • Stockholder Information
  • Analysts Coverage
  • FAQs
  • Glossary of Terms
  • Press Releases
  • In the News
  • Awards
  • Publications
  • Links

TURNING NOVEL DISCOVERIES INTO
INNOVATIVE HEALTH CARE SOLUTIONS.

KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the United States health care system $20 billion per year.


  • INVESTORS »
  • What is Biofilm? |
  • Stock Quote |
  • Events & Presentations |
  • Financial Reports |
  • Stockholder Information |
  • Analysts Coverage |
  • FAQs |
  • Glossary of Terms

Reports & Financials


Annual Reports

  • 2010 Year End Financial Statements
  • 2010 Year End MD&A
  • 2009 Year End Financial Statements
  • 2009 Year End MD&A
  • 2008 Year End Financial Statements
  • 2008 Year End MD&A
  • 2007 Annual Report
  • 2006 Annual Report
  • 2005 Annual Report
  • 2004 Annual Report

Financial Statements

  • 2010 Q4 Financial Statements
  • 2010 Q4 MD&A
  • 2010 Q3 Financial Statements
  • 2010 Q3 MD&A
  • 2010 Q2 Financial Statements
  • 2010 Q2 MD&A
  • 2010 Q1 Financial Statements
  • 2010 Q1 MD&A
  • 2009 Year End Financial Statements
  • 2009 Year End MD&A
  • 2009 Q3 Financial Statements
  • 2009 Q3 MD&A

HOME | TERMS OF USE

©Kane Biotech Inc. 2011.